NLGN3 and central nervous system cancer: Venkatesh et al. reported that the synaptic protein neuroligin-3 (NLGN3) activates the PI3K-mTOR pathway and induces the feedforward expression of NLGN3 in glioma cells, and NLGN3 promotes robust high-grade glioma cell proliferation [8].